Collegium Pharmaceutical, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Collegium Pharmaceutical, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Collegium Pharmaceutical, Inc. do? Business model and key facts
Get the full picture of Collegium Pharmaceutical, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees (FY): 357
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Stocks related to Collegium Pharmaceutical, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Collegium Pharmaceutical, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Collegium Pharmaceutical, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
